Patents by Inventor Lauren Elizabeth Jensen

Lauren Elizabeth Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10655146
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: May 19, 2020
    Assignee: BIOMUNE COMPANY
    Inventors: Motoyuki Esaki, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • Publication number: 20180363006
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Application
    Filed: August 28, 2018
    Publication date: December 20, 2018
    Inventors: MOTOYUKI ESAKI, LAUREN ELIZABETH JENSEN, KRISTI M. DORSEY
  • Patent number: 10072272
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: September 11, 2018
    Assignee: BIOMUNE COMPANY
    Inventors: Motoyuki Esaki, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • Publication number: 20170298386
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Application
    Filed: November 24, 2014
    Publication date: October 19, 2017
    Inventors: Motoyuki ESAKI, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • Publication number: 20150110835
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Application
    Filed: November 24, 2014
    Publication date: April 23, 2015
    Inventors: Motoyuki ESAKI, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • Patent number: 8927270
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: January 6, 2015
    Assignee: Zeon Corporation
    Inventors: Motoyuki Esaki, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • Publication number: 20100092510
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Application
    Filed: March 28, 2008
    Publication date: April 15, 2010
    Inventors: Esaki Motoyuki, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • Publication number: 20080241188
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Application
    Filed: March 30, 2007
    Publication date: October 2, 2008
    Applicant: ZEON CORPORATION
    Inventors: Motoyuki Esaki, Lauren Elizabeth Jensen, Kristi M. Dorsey